Activatable UCL/CT/MR-enhanced in vivo imaging-guided radiotherapy and photothermal therapy

J Mater Chem B. 2022 Jan 26;10(4):549-561. doi: 10.1039/d1tb02006d.

Abstract

Although sophisticated radiotherapy (RT) technology has been widely applied in clinical oncotherapy, unsatisfactory therapeutic effects due to hypoxic tumor microenvironments and complications are still prevalent. Herein, copper sulphide nanoparticles (CuS NPs) wrapped on the surface of upconversion nanoparticles (UCNPs) via manganese dioxide (MnO2) coatings were synthesized for O2 self-supplementing and enhanced combinational RT/photothermal therapy (PTT). In our design, the nanoplatforms can be rapidly enriched at tumor sites by the enhanced permeability and retention (EPR) effect and respond to the tumor microenvironment. The surface MnO2 coatings can interact with over-expressed H2O2 in tumors and cause an abundant generation of oxygen for hypoxic improvement, leading to an enhanced RT. More importantly, by irradiation with near-infrared light, the scattered CuS NPs can convert light energy into heat to destroy tumor cells and reinforce the therapeutic effects of RT. Furthermore, these NPs also displayed excellent performances in upconversion fluorescence imaging (UCL), computerized tomographic (CT) scanning and magnetic resonance imaging (MRI), demonstrating a potential imaging-guided cancer therapy system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Copper / chemistry
  • Female
  • Humans
  • Liver Neoplasms, Experimental / diagnostic imaging
  • Liver Neoplasms, Experimental / radiotherapy
  • Magnetic Resonance Imaging*
  • Materials Testing
  • Mice
  • Mice, Nude
  • Nanoparticles / chemistry
  • Optical Imaging*
  • Photothermal Therapy*
  • Sulfides / chemistry
  • Tomography, X-Ray Computed*

Substances

  • Sulfides
  • Copper